Table 1.

Aptamer-based point-of-care devices for rapid, affordable, sensitive and specific detection of cognate molecules.

Point-of-care assays	Remarks	Reference
Smartphone	Detection of Zika virus	20
Smartphone	Similar platform for rapid detection of Zika virus is being adapted for COVID-19 by researchers in University of Utah	23
Aptamer-linked immunosorbent assay (ALISA)	Detection of active Mycobacterium tuberculosis from sputum samples	65
Aptamer-linked immunosorbent assay (ALISA)	Detection of Mycobacteria tuberculosis in serum and sputum samples	72
Aptamer-magnetic bead-electrochemiluminescence (ECL) assay	Detection of brain natriuretic peptide in serum samples	11
Dot-blotting	Detection of vaccinia virus	60
Gold nanoparticle (GNP) aggregation assay	Detection of Staphylococcal enterotoxin B	53
Upconverting phosphors/nanoparticles (UCNP) assay	Detection of Salmonella typhimurium and Staphylococcus aureus	22
Lateral flow assay	Detection of thrombin in human plasma samples	92
Lateral flow assay	Detection of cortisol	17
Lateral flow assay	Detection of dopamine in urine	18
Lateral flow assay	Detection of nervous necrosis virus	51